Purple Biotech OverviewPurple Biotech's common stock is $0.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2026), PPBT shows a common stock of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PPBT's common stock is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Purple Biotech is outperforming or lagging.
Tracking PPBT's common stock over time shows whether Purple Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Purple Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.
Purple Biotech's common stock is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
